BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11958920)

  • 1. Efficacy, toxicity, and cost-effectiveness of single-dose versus fractionated hemibody irradiation (HBI).
    Sarin R; Budrukkar A
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1146; author reply 1146-7. PubMed ID: 11958920
    [No Abstract]   [Full Text] [Related]  

  • 2. Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA).
    Salazar OM; Sandhu T; da Motta NW; Escutia MA; Lanzós-Gonzales E; Mouelle-Sone A; Moscol A; Zaharia M; Zaman S
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):765-75. PubMed ID: 11395246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous metastases--RTOG 88-22.
    Scarantino CW; Caplan R; Rotman M; Coughlin C; Demas W; Delrowe J
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):37-48. PubMed ID: 8823257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a modified hemi-body irradiation technique for metastatic carcinoma of the prostate: report of a 10-year experience.
    Bashir FA; Parry JM; Windsor PM
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):591-8. PubMed ID: 18562185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single fraction radiotherapy for bone metastases: are all questions answered?
    Chander SS; Sarin R
    Radiother Oncol; 1999 Aug; 52(2):191-3. PubMed ID: 10577706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases.
    Poulter CA; Cosmatos D; Rubin P; Urtasun R; Cooper JS; Kuske RR; Hornback N; Coughlin C; Weigensberg I; Rotman M
    Int J Radiat Oncol Biol Phys; 1992; 23(1):207-14. PubMed ID: 1374061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half-body irradiation with tomotherapy for pain palliation in metastatic breast cancer.
    Furlan C; Trovo M; Drigo A; Capra E; Trovo MG
    J Pain Symptom Manage; 2014 Jan; 47(1):174-80. PubMed ID: 23796585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Half body irradiation for palliation of widespread metastatic bone disease.
    Chua ET; Chua EJ; Sethi VK
    Ann Acad Med Singap; 1994 Mar; 23(2):204-8. PubMed ID: 7521611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone metastases radiotherapy: Multi-approaches literature review].
    Le Fèvre C; Antoni D; Thiéry A; Noël G
    Cancer Radiother; 2018 Dec; 22(8):810-825. PubMed ID: 30001971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 32P therapy and sequential hemibody irradiation (HBI) for bony metastases as methods of whole body irradiation.
    Aziz H; Choi K; Sohn C; Yaes R; Rotman M
    Am J Clin Oncol; 1986 Jun; 9(3):264-8. PubMed ID: 2425617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half body irradiation of patients with multiple bone metastases: a phase II trial.
    Berg RS; Yilmaz MK; Høyer M; Keldsen N; Nielsen OS; Ewertz M
    Acta Oncol; 2009; 48(4):556-61. PubMed ID: 18979285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of 3D-conformal half body irradiation in patients with multiple bone metastases.
    Macchia G; Ferro M; Cilla S; Buwenge M; Ianiro A; Boccardi M; Picardi V; Ferro M; Arena E; Zamagni A; Cammelli S; Valentini V; Morganti AG; Deodato F
    Clin Exp Metastasis; 2018 Dec; 35(8):747-752. PubMed ID: 30251079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemibody irradiation (HBI) for metastatic bone pain in two histologically distinct groups of patients.
    Hoskin PJ; Ford HT; Harmer CL
    Clin Oncol (R Coll Radiol); 1989 Nov; 1(2):67-9. PubMed ID: 2484791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-irradiation for painful bone metastases - a systematic review.
    Wong E; Hoskin P; Bedard G; Poon M; Zeng L; Lam H; Vulpe H; Tsao M; Pulenzas N; Chow E
    Radiother Oncol; 2014 Jan; 110(1):61-70. PubMed ID: 24094630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative single-fraction radiation therapy: how much more evidence is needed?
    Kachnic L; Berk L
    J Natl Cancer Inst; 2005 Jun; 97(11):786-8. PubMed ID: 15928293
    [No Abstract]   [Full Text] [Related]  

  • 16. Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial.
    van den Hout WB; van der Linden YM; Steenland E; Wiggenraad RG; Kievit J; de Haes H; Leer JW
    J Natl Cancer Inst; 2003 Feb; 95(3):222-9. PubMed ID: 12569144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single fraction radiotherapy for bone metastases: clinically effective, time efficient, cost conscious and still underutilized in the United States?
    Hartsell WF; Konski AA; Lo SS; Hayman JA
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):652-4. PubMed ID: 19744843
    [No Abstract]   [Full Text] [Related]  

  • 18. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases.
    Wu JS; Wong R; Johnston M; Bezjak A; Whelan T;
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):594-605. PubMed ID: 12573746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metastases: ongoing controversies in fractionation schedules.
    Wu JS; Bezjak A
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):908-9. PubMed ID: 11183738
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiation for bone metastases: conventional techniques and the role of systemic radiopharmaceuticals.
    Janjan NA
    Cancer; 1997 Oct; 80(8 Suppl):1628-45. PubMed ID: 9362430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.